C. Cerni

发表

ADP‐ribosylation of p53 tumor suppressor protein: Mutant but not wild‐type p53 is modified

J. Węsierska‐Gądek, A. Bugajska-Schretter, C. Cerni, 1996, Journal of cellular biochemistry.

Subcellular localisation of Cdc25A determines cell fate

C. Cerni, C. Leisser, G. Rosenberger, 2004, Cell Death and Differentiation.

Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YY1.

C. Seelos, M. Henriksson, C. Cerni, 1997, Current topics in microbiology and immunology.

YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc

C. Cerni, B. Lüscher, M. Austen, 1998, Oncogene.

Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras

C. Schamberger, C. Cerni, Klaus W Sommer, 2003, Oncogene.

PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation

E. Kremmer, R. Kraft, C. Schamberger, 2005, Oncogene.

Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigens.

C. Cerni, M. Bagot, G. Meneguzzi, 1996, Research in virology.

Nuclear Ras: Unexpected subcellular distribution of oncogenic forms

J. Węsierska‐Gądek, C. Cerni, W. Mosgoeller, 2001, Journal of cellular biochemistry. Supplement.

Oncogenic c‐H‐ras deregulates survivin expression: An improvement for survival

C. Cerni, G. Krupitza, K. Holzmann, 2007, FEBS letters.

[Results of a comparative therapy study for inoperable lung cancer].

C. Cerni, E. Ogris, M. Micksche, 1982, Onkologie.

Biological effects of high level c-myc expression in FR3T3 fibroblasts.

C. Cerni, K. Marcu, M. Zerlin, 1986, Current topics in microbiology and immunology.

c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts.

C. Cerni, F. Cuzin, K. Marcu, 1986, Current topics in microbiology and immunology.

Cdc25A phosphatase suppresses apoptosis induced by serum deprivation

C. Cerni, C. Leisser, G. Rosenberger, 2001, Oncogene.

Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances

C. Cerni, R. Dudczak, D. Magometschnigg, 1983, Experientia.

Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C

A. Albini, C. Cerni, N. Katunuma, 1999, International journal of cancer.

Transfer of 'immortalizing' oncogenes into rat fibroblasts induces both high rates of sister chromatid exchange and appearance of abnormal karyotypes.

C. Cerni, F. Cuzin, E. Mougneau, 1987, Experimental cell research.

Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.

C. Seelos, M. Henriksson, C. Cerni, 1995, Oncogene.

Sister chromatid exchange in FR3T3 rat fibroblasts transformed by Simian virus 40.

C. Cerni, E. Mougneau, 1984, Experimental cell research.

Effect of tissue culture variables on sister chromatid exchange in a nontransformed rat cell line

C. Cerni, 1984, In Vitro.

Proteolytic Enzymes in the Treatment of Malignant Pleural Effusions and Solid Metastases

C. Cerni, M. Micksche, H. Wrba, 1976 .

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

R. Lathe, M. Kieny, C. Cerni, 1991, Virology.

Stimulation of immune response in lung cancer patients by vitamin A therapy.

C. Cerni, M. Micksche, H. Wrba, 1977, Oncology.

Immunosuppression by human placenta lactogen (HPL) and the pregnancy-specific beta 1-glycoprotein (SP-1). Inhibition of mitogen-induced lymphocyte transformation.

C. Cerni, H. Bohn, G. Tatra, 1977, Archiv fur Gynakologie.

The detection and measurement of oncodevelopmental proteins in gynecological malignant disease

C. Cerni, G. Tatra, 2005, Archives of gynecology.

Caspase-9 plays a marginal role in serum starvation-induced apoptosis.

C. Schamberger, C. Cerni, C. Gerner, 2005, Experimental cell research.

Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1

M. Henriksson, C. Cerni, L. Larsson, 2002, Oncogene.

Targeted Inhibition of Telomerase in Human Cancer: Will It Be a Double-Edged Sword?

C. Cerni, M. Wieser, S. Sasgary, 2001, Oncology Research and Treatment.

Telomeres, telomerase, and myc. An update.

C. Cerni, Christa Cerni, 2000, Mutation research.

The human trithorax protein hASH2 functions as an oncoprotein.

E. Kremmer, C. Cerni, A. Wellmann, 2008, Cancer research.

Expression of mouse RNase MRP RNA in human embryonic kidney 293 cells

C. Cerni, W. Rossmanith, R. Karwan, 1997, Molecular Biology Reports.

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

H. Bergmeister, C. Pirker, W. Berger, 2006, Cancer research.

Successive steps in the process of immortalization identified by transfer of separate bovine papillomavirus genes into rat fibroblasts.

D. Lowy, J. Schiller, C. Cerni, 1989, Proceedings of the National Academy of Sciences of the United States of America.

bFGF rescues 423‐cells from serum starvation‐induced apoptosis downstream of activated caspase‐3

C. Schamberger, C. Cerni, C. Gerner, 2004, FEBS letters.

Detection and quantification of transcripts for the catalytic subunit TERT and the RNA component of telomerase in rat tissue.

W. Berger, C. Cerni, K. Holzmann, 2003, Analytical biochemistry.

Papillomaviruses as Promoting Agents in Human Epithelial Tumors

C. Seelos, C. Cerni, 1995 .

Immunosuppression by human placenta lactogen (HPL) and the pregnancy-specificβ1-glycoprotein (SP-1)

C. Cerni, H. Bohn, G. Tatra, 1977, Archiv für Gynäkologie.

Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.

C. Cerni, C. Leisser, S. Maier, 2005, Mutation research.

ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.

J. Węsierska‐Gądek, G. Schmid, C. Cerni, 1996, Biochemical and biophysical research communications.

Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.

C. Cerni, K. Marcu, M. Zerlin, 1987, Oncogene.

Immortalization of primary rat embryo cells by human papillomavirus type 11 DNA is enhanced upon cotransfer of ras.

C. Cerni, G. Meneguzzi, K. Patočka, 1990, Virology.

Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events.

C. Cerni, F. Cuzin, E. Mougneau, 1988, Oncogene research.

CDC25A Mediates Survival by Activating AKT Kinase

C. Cerni, C. Leisser, G. Rosenberger, 2001, TheScientificWorldJournal.

The cytoplasmic truncated receptor tyrosine kinase ALK‐ homodimer immortalizes and cooperates with ras in cellular transformation

C. Cerni, S. Fassl, D. Polgar, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformation.

D. Lowy, J. Schiller, C. Cerni, 1990, Oncogene.

Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.

C. Cerni, M. Micksche, 1975, Acta neuropathologica. Supplementum.